Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Sigbjorn Berentsen"'
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/9c1829eac4dc493f89f0c9fa3a96a3ac
Autor:
Alexander Roth, Wilma Barcellini, Shirley D’Sa, Yoshitaka Miyakawa, Catherine M. Broome, Marc Michel, David J. Kuter, Bernd Jilma, Tor Henrik Anderson Tvedt, Ilene C. Weitz, Parija Patel, Xiaoyu Jiang, Caroline Reuter, Jun Su, Frank Shafer, Michelle Lee, Sigbjorn Berentsen
Publikováno v:
Haematologica, Vol 107, Iss 7 (2022)
Externí odkaz:
https://doaj.org/article/ea05723d0a0f40ebb76ce93393407b84
Autor:
Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, Bernd Jilma, Marc Michel, Ilene C. Weitz, Masaki Yamaguchi, Jun-ichi Nishimura, Josephine M.I. Vos, Joan Cid, Michael Storek, Nancy Wong, Ronnie Yoo, Deepthi Jayawardene, Shruti Srivastava, Marek Wardęcki, Frank Shafer, Michelle Lee, Catherine M. Broome
Publikováno v:
EClinicalMedicine, Vol 74, Iss , Pp 102733- (2024)
Summary: Background: Cold agglutinin disease (CAD) is a rare autoimmune haemolytic anaemia mediated by the classical complement pathway (CP). Sutimlimab selectively targets complement C1s inhibiting classical CP activation. In CADENZA Part A (26-week
Externí odkaz:
https://doaj.org/article/3d87b23487004a108e8a911cd7c2cb67
Autor:
Sigbjørn Berentsen, Suvro Sankha Datta
Publikováno v:
The Lancet Regional Health - Southeast Asia, Vol 25, Iss , Pp 100410- (2024)
Externí odkaz:
https://doaj.org/article/305b86938001496cbcdcc4d845d26e0e
Publikováno v:
Hemato, Vol 3, Iss 4, Pp 574-594 (2022)
The last 2 decades have seen great progress in understanding the pathogenesis of cold agglutinin disease (CAD) and development of effective therapies. Cold agglutinins can cause hemolytic anemia as well as peripheral circulatory symptoms such as acro
Externí odkaz:
https://doaj.org/article/5cd89b739fbe4aef947c9a3f6fbd6fa5
Autor:
Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, Shirley D’sa, Bernd Jilma, Marc Michel, Ilene C Weitz, Masaki Yamaguchi, Jun-Ichi Nishimura, Josephine Vos, Joan Cid, Michael Storek, Nancy Wong, Ronnie Yoo, Deepthi Jayawardene, Shruti Srivastava, Marek Wardęcki, Frank Shafer, Michelle Lee, Catherine M Broome
Publikováno v:
HemaSphere, Vol 7, p e83270db (2023)
Externí odkaz:
https://doaj.org/article/34c6141f83354a40a8c76a7bba4fdcb6
Autor:
Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, Shirley D’sa, Bernd Jilma, Marc Michel, Ilene C Weitz, Masaki Yamaguchi, Jun-Ichi Nishimura, Josephine Vos, Joan Cid, Michael Storek, Nancy Wong, Ronnie Yoo, Deepthi Jayawardene, Katarina Kralova, Marek Wardęcki, Frank Shafer, Michelle Lee, Catherine M Broome
Publikováno v:
HemaSphere, Vol 7, p e3331235 (2023)
Externí odkaz:
https://doaj.org/article/bec69a5d1b2b4ad8afba22ee30dce3db
Autor:
Sigbjørn Berentsen
Publikováno v:
HemaSphere, Vol 7, Iss 5, p e879 (2023)
Cold agglutinin disease (CAD) is a rare autoimmune hemolytic anemia and a bone marrow clonal lymphoproliferative disorder. Hemolysis in CAD is complement-dependent and mediated by the classical activation pathway. Patients also frequently suffer from
Externí odkaz:
https://doaj.org/article/b169b3a60a5d4c46869092945120877d
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Autoimmune hemolytic anemia (AIHA) is defined by increased erythrocyte turnover mediated by autoimmune mechanisms. While corticosteroids remain first-line therapy in most cases of warm-antibody AIHA, cold agglutinin disease is treated by targeting th
Externí odkaz:
https://doaj.org/article/c68af42595fa4d3e9c8edb0bd07b822e
Autor:
Sarah A. Lau-Braunhut, Hannah Stone, Griffin Collins, Sigbjørn Berentsen, Benjamin S. Braun, Matt S. Zinter
Publikováno v:
Blood Advances, Vol 3, Iss 22, Pp 3575-3578 (2019)
Externí odkaz:
https://doaj.org/article/a63a1657bcf1481e81261c9d57936342